Earlier studies suggest that butyrate has colonic differentiating and
nutritional effects and that acarbose increases butyrate production. T
o determine the effects of acarbose on colonic fermentation, subjects
were given 50-200 mg acarbose or placebo (cornstarch), three times per
day, with meals in a double-blind crossover study. Fecal concentratio
ns of starch and starch-fermenting bacteria were measured and fecal fe
rmentation products determined after incubation of fecal suspensions w
ith and without added substrate for 6 and 24 h. Substrate additions we
re cornstarch, cornstarch plus acarbose and potato starch. Dietary sta
rch consumption was similar during acarbose and placebo treatment peri
ods, but fecal starch concentrations were found to be significantly gr
eater with acarbose treatment. Ratios of starch-fermenting to total an
aerobic bacteria were also significantly greater with acarbose treatme
nt. Butyrate in feces, measured either as concentration or as percenta
ge of total short-chain fatty acids, was significantly greater with ac
arbose treatment than with placebo treatment. Butyrate ranged from 22.
3 to 27.5 mol/100 mol for the 50-200 mg, three times per day doses of
acarbose compared with 18.3-19.3 mol/100 mol for the comparable placeb
o periods. The propionate in fecal total short-chain fatty acids was s
ignificantly less with acarbose treatment (10.7-12.1 mol/100 mol) than
with placebo treatment (13.7-14.2 mol/100 mel). Butyrate production w
as significantly greater in fermentations in samples collected during
acarbose treatment, whereas production of acetate and propionate was s
ignificantly less. Fermentation decreased when acarbose was added dire
ctly to cornstarch fermentations. Acarbose effectively augmented colon
ic butyrate production by several mechanisms; it reduced starch absorp
tion, expanded concentrations of starch-fermenting and butyrate-produc
ing bacteria and inhibited starch use by acetate- and propionate-produ
cing bacteria.